IO Biotech, Inc.
IO Biotech, Inc.（IOBT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
iobt · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年4月11日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$0.50
Consensus
$0.50
+12400.0% upside
Low
$0.50
Median: $0.5 · Last Close: $0.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.00 | ↓ 5.00% |
1-day model range: $0–$0. Peak: $0 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · IOBT · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-01-26 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2025-10-22 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-09-30 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2025-09-29 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-08-12 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on IO Biotech, Inc. (IOBT) stock. Of the recent 26 rating actions, 0 were upgrades and 3 were downgrades. 6 analysts currently cover IOBT.
分析师推荐趋势
IOBT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$14M
↓ 74.4% YoY
Revenue Next Year
$18M
↑ 28.6% YoY
EPS This Year
$-0.29
EPS Next Year
$-0.31
↑ 8.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast IOBT EPS of $-0.29 for the current fiscal year, based on estimates from 1 analysts. The IOBT revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IOBT 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IOBT 的共识目标价为 $0.50（+12400.0% 上行空间），分析师共识为 Buy。
IOBT 的短期预测（明日）为 $0.00（-5.00%）。
IO Biotech, Inc. 在 NASDAQ 上市，代码 IOBT。IOBT 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
IOBT 预测 · 8 个问题根据 6 位华尔街分析师，IOBT 的 12 个月平均目标价为 $0.50，最高 $0.50、最低 $0.50。若有图表，中位目标价可在上方查看。相对当前价 $0.00，隐含约 +12400.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.